Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas S Scanlan

Showing results (1-10 of 117) with videos related to

Pageof 12
Sort By:
The Journal of Clinical Endocrinology and Metabolism|May 24, 2011
Endogenous 3-iodothyronamine (T1AM): more than we bargained forThomas S Scanlan
Heart Failure Reviews|November 13, 2008
Sobetirome: a case history of bench-to-clinic drug discovery and developmentThomas S Scanlan
Endocrinology|January 1, 2009
Minireview: 3-Iodothyronamine (T1AM): a new player on the thyroid endocrine team?Thomas S Scanlan
Bioorganic & Medicinal Chemistry Letters|September 24, 2004
Design and evaluation of novel nonsteroidal dissociating glucocorticoid receptor ligandsNilesh Shah, Thomas S Scanlan
Chembiochem : a European Journal of Chemical Biology|June 10, 2003
Binding and catalysis: a thermodynamic study on a catalytic antibody systemHerschel Wade, Thomas S Scanlan
Synthetic Communications|September 26, 2017
THE SYNTHESIS OF <sup>13</sup>C<sub>9</sub>-<sup>15</sup>N-LABELED 3,5-DIIODOTHYRONINE AND THYROXINESarah A Hackenmueller, Thomas S Scanlan
Tetrahedron|March 21, 2017
New synthetic routes to thyroid hormone analogs: d<sub>6</sub>-sobetirome, <sup>3</sup>H-sobetirome, and the antagonist NH-3Andrew T Placzek, Thomas S Scanlan
Molecular Interventions|January 6, 2006
Few things in life are "free": cellular uptake of steroid hormones by an active transport mechanismBenjamin C Lin, Thomas S Scanlan
Journal of Medicinal Chemistry|August 14, 2020
A CNS-Targeting Prodrug Strategy for Nuclear Receptor ModulatorsSkylar J Ferrara, Thomas S Scanlan
Molecular Biosystems|July 13, 2010
3-Iodothyronamine (T(1)AM): a new chapter of thyroid hormone endocrinology?Alexandra G Ianculescu, Thomas S Scanlan
Pageof 12

Showing results (1-10 of 117) with videos related to

Sort By:
Pageof 12
The Journal of Clinical Endocrinology and Metabolism|May 24, 2011
Endogenous 3-iodothyronamine (T1AM): more than we bargained forThomas S Scanlan
Heart Failure Reviews|November 13, 2008
Sobetirome: a case history of bench-to-clinic drug discovery and developmentThomas S Scanlan
Endocrinology|January 1, 2009
Minireview: 3-Iodothyronamine (T1AM): a new player on the thyroid endocrine team?Thomas S Scanlan
Bioorganic & Medicinal Chemistry Letters|September 24, 2004
Design and evaluation of novel nonsteroidal dissociating glucocorticoid receptor ligandsNilesh Shah, Thomas S Scanlan
Chembiochem : a European Journal of Chemical Biology|June 10, 2003
Binding and catalysis: a thermodynamic study on a catalytic antibody systemHerschel Wade, Thomas S Scanlan
Synthetic Communications|September 26, 2017
THE SYNTHESIS OF <sup>13</sup>C<sub>9</sub>-<sup>15</sup>N-LABELED 3,5-DIIODOTHYRONINE AND THYROXINESarah A Hackenmueller, Thomas S Scanlan
Tetrahedron|March 21, 2017
New synthetic routes to thyroid hormone analogs: d<sub>6</sub>-sobetirome, <sup>3</sup>H-sobetirome, and the antagonist NH-3Andrew T Placzek, Thomas S Scanlan
Molecular Interventions|January 6, 2006
Few things in life are "free": cellular uptake of steroid hormones by an active transport mechanismBenjamin C Lin, Thomas S Scanlan
Journal of Medicinal Chemistry|August 14, 2020
A CNS-Targeting Prodrug Strategy for Nuclear Receptor ModulatorsSkylar J Ferrara, Thomas S Scanlan
Molecular Biosystems|July 13, 2010
3-Iodothyronamine (T(1)AM): a new chapter of thyroid hormone endocrinology?Alexandra G Ianculescu, Thomas S Scanlan
Pageof 12